Longitudinal Assessment of Ovarian Reserve in Adolescents With Lymphoma
-
- STATUS
- Not Recruiting
Summary
This clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas.
Description
The purpose of this study is to compare anti mullerian hormone (AMH), follicle stimulating hormone (FSH), and estradiol (E2) between patients at baseline and cross section of controls and again between patients at 12 months off therapy and cross section of controls; to describe the trajectory of AMH, FSH, and E2 from baseline to 12 months after completion of gonadotoxic cancer treatment; to evaluate degree of change of AMH/FSH/E2 from baseline to end of therapy in patients; and to evaluate degree of recovery of AMH/FSH/E2 from end of therapy to 12 months off therapy.
Details
| Condition | lymphoma |
|---|---|
| Age | 29years or below |
| Clinical Study Identifier | TX6096 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.